Mr. James Paul Ronyak Jr. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4881 Sugar Maple Dr, 88mdg/sgcpz, Wright Patterson Afb, OH 45433 Phone: 937-257-8696 |
Amie Daryanani, OTR Occupational Therapist - Hand Medicare: Not Enrolled in Medicare Practice Location: 4881 Sugar Maple Dr, Wright Patterson Afb, OH 45433 Phone: 937-257-8753 |
Mrs. Chelsea Orr, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4811 Sugar Maple Dr, Wright Patterson Afb, OH 45433 Phone: 937-257-9612 |
Tina Snyder, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4881 Sugar Maple Dr, Wright Patterson Afb, OH 45433 Phone: 937-522-4722 |
Josef Samuel Otto, OTR Occupational Therapist - Hand Medicare: Not Enrolled in Medicare Practice Location: 488 Sugarmaple Rd, 88mdg/sghj, Wright Patterson Afb, OH 45433 Phone: 937-427-0771 |
News Archive
Evotec AG today announced that it has entered into a license and collaboration agreement with Zhejiang Jingxin Pharmaceutical Co., Ltd for EVT 201, a novel potential treatment for insomnia. The agreement grants Jingxin Pharma exclusive rights to develop and market the drug candidate in China. In return, Evotec will receive a small upfront payment, together with commercial milestones and significant royalties.
Today's health policy headlines include reports that the House yesterday approved the $3.5 trillion budget plan proposed by Paul Ryan - which includes deep cuts in entitlements and will likely trigger the election-year fiscal debate.
Ask any health professional who cares for children and they will tell you: When H1N1 flu hits, it can be very severe. In the last four months of 2009, nearly 240 children died in the United States from H1N1 flu—more than three times as many child deaths as in a typical non-H1N1 flu season.
Cross-sectional studies have reported an association between major depressive episode (MDE) and obesity. The objective of this longitudinal analysis was to determine whether MDE increase the risk of becoming obese over a 10-year period.
Scientists at Karolinska Institutet have evaluated a new Alzheimer's therapy in which the patients receive an implant that stimulates the growth of a certain type of nerve cell. The results, which are published in the scientific journal Alzheimer's & Dementia, suggest that the introduction of a nerve growth factor can prevent neuronal degradation in Alzheimer's patients.
› Verified 2 days ago